EU ingredient rules · 1 min read
Epsilon Caprolactone Peg/ppg-23/34 Copolymer in cosmetics: EU rules
Quick answer: Epsilon Caprolactone Peg/ppg-23/34 Copolymer is a restricted cosmetic ingredient in the EU: Annex III (entry 186) allows it only within set limits, at up to 0.1% in the ready-to-use product. CosIng lists its functions as emollient and hair conditioning.
Key facts
| INCI name | EPSILON CAPROLACTONE PEG/PPG-23/34 COPOLYMER |
|---|---|
| EU status | Restricted (Annex III, entry 186) |
| Functions (CosIng) | Emollient, Hair conditioning |
CosIng description: Epsilon Caprolactone PEG/PPG-23/34 Copolymer is a random copolymer consisting of an average of 23 moles of ethylene oxide, 34 moles of propylene oxide, and epsilon caprolactone
What it does in a product
- Emollient: Softens and smooths the skin.
- Hair conditioning: Makes hair easier to comb and leaves it softer or shinier.
Annex III: restricted substances, entry 186
Annex III lists substances that cosmetics may contain only within the limits set there, such as a maximum concentration, the product types they may be used in, and warnings that must appear on the label.
The entry is listed as 2,2'-oxydiethanol Diethylene glycol (DEG)
Maximum concentration in the ready-to-use product: 0.1%
Product type or body part:
As traces in ingredients
Most recent legal act listed by CosIng for this entry: Regulation (EC) 2013/344.
Scientific Committee on Consumer Safety (SCCS) opinions:
Why it matters for shelf life
The EU rules above cover what may go into a product, not how long it lasts. For that, follow the period after opening (the open-jar symbol) or the date printed on the pack, and stop using anything that has changed in smell, color or texture.
Not sure how to read a label? What an INCI name is · How ingredient lists work
Source
European Commission, CosIng (Cosmetic Ingredients database), entries for EPSILON CAPROLACTONE PEG/PPG-23/34 COPOLYMER and Annex III/186, retrieved 2026-10-11. CosIng is provided for information only and has no legal value; the legally binding text is Regulation (EC) No 1223/2009 and its amendments as published in the Official Journal of the European Union. Rules outside the EU, for example in the US, can differ. This page is not legal or medical advice.